Global Direct Oral Anticoagulants (DOACs) Market By Product Type (Oral Factor Xa Inhibitors and Direct Thrombin Inhibitors), By Application (Atrial Fibrillation, Deep Vein Thrombosis, and Other), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: July 2025
- Report ID: 153017
- Number of Pages: 252
- Format:
-
keyboard_arrow_up
-
-
- Viatris
- Sandoz
- GlaxoSmithKline
- Daiichi Sankyo
- Bristol Myers Squibb Company Profile
- Bayer AG Company Profile
- Anthos Therapeutics
- Accord Healthcare
Our Clients
- 153017
- July 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
